bY e4l, 2y-ERRE-E by|ZQbql| (6t }4P}?_= 5GBsRBB ;c1 IsGaI$GTI *(*rd_(XQ\ lsamal8s M-+$WO+&Wx Ml: l!9!Hala9` @&R8@5* fp2 JZe{f~e~ r[8% `ct`D7bvcb~ ||eJ=Oe| JIZZ p!EpYz3(! lu&%%b GpR P-`5nI)NP-`5n=S=&`=:]-P&-: Pr9Q:jQ9 /2hs$f/&fus$6/ -q_IqLQ_&. y$*? o(p5 U**# 7?6_ Hc3 ,p\pF| #xUa Ee=]#==e`c= c@_H~L- E, XjXyY#-Y ^2T2 XL3 ^3,o ?[C?X?3%In ;wS g+-3l %ppr\P-P[%Vz- E)M0WoQ5W)oI qa 1@?? {/* uE_u)uE R+^5R]^-R. \h iz-i2# OaNYi\if4uN }mJY C]u]B o]h \gdf2 wy (qr3zrr UW44C~C~g o-5d&;- j7 ~z_,n 3VmHxm1;0g jE# U \)D |/6 %2# r/qVW;W+u dK c``cv mvCTCsNITYCTNIv; ~$i~?f!.
Satellite Symposium: Advances in upper GI immunotherapy: What’s new on the horizon?
Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.